Relapsed/Refractory Small Cell Lung Cancer
specificNon-small cell lung carcinoma that does not respond to treatment.
11
Centers
11
Active Trials
—
Cancer Funding
Top Centers for Relapsed/Refractory Small Cell Lung Cancer(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 54.5 |
| 2 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 54.5 |
| 3 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 54.5 |
| 4 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 54.5 |
| 5 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 54.5 |
| 6 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 54.5 |
| 7 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 54.5 |
| 8 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 54.5 |
| 9 | Boston University Cancer CenterBoston, MA Active Research Program | 54.5 |
| 10 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 54.5 |
| 11 | Active Research Program | 54.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →